Botox
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. 
Subscribe to this data using MyMedWorm.
Subscribe to this data using GoogleReader.
Subscribe to this data using Bloglines.
Subscribe to this data using MyYahoo.
Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.
This page shows you your search results in order of date.
1052 records returned
[Treatment of drooling with botulinum toxin type A in cerebral palsy.]
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
PMID: 19921629 [PubMed - as supplied by publisher] (Source: Revista de Neurologia)
Source: Revista de Neurologia - November 21, 2009 Category: Neurology Authors: Duarte CS, Alves TR, Azeredo PM, Almeida SI Tags: Rev Neurol Source Type: journals
Treatment success for overactive bladder with urinary urge incontinence refractory to oral antimuscarinics: a review of published evidenceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusions:
A treatment success definition that encompasses the many components of underlying OAB with UUI symptoms is currently not practical as a consequence of difficulties in measuring urgency. The treatment success outcome of >=50% improvement in incontinence episodes was associated with a clinically meaningful improvement in disease-specific HRQoL for those with neurogenic OAB with UUI. The recommended success definition is less restrictive than a measure such as complete continence but includes patients who are satisfied with treatment and experience meaningful improvement in symptoms. A standardized measure of tre...
Source: BioMed Central - November 20, 2009 Category: Journals (General) Authors: Jonathan CampbellKatharine GriesJonathan WatanabeArliene RaveloRoger DmochowskiSean Sullivan Source Type: journals
Merz Pharmaceuticals Announces Approval Of Post-stroke Upper Limb Spasticity Indication For Xeomin(R) In The EUEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Merz Pharmaceuticals announced Xeomin®, the first botulinum toxin type A free from complexing proteins has been granted an extension of indication for post-stroke spasticity of the upper limb presenting with flexed wrist and clenched fist in adults in various European countries. Xeomin® was already granted approval for post-stroke spasticity of the upper limb in early 2009 in Canada, Mexico and Argentina. (Source: Stroke / Neuroprotection News From Medical News Today)
Source: Stroke / Neuroprotection News From Medical News Today - November 19, 2009 Category: Neurology Tags: Stroke Source Type: news
Merz Pharmaceuticals Announces Approval Of Post-stroke Upper Limb Spasticity Indication For Xeomin(R) In The EUEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Merz Pharmaceuticals announced Xeomin®, the first botulinum toxin type A free from complexing proteins has been granted an extension of indication for post-stroke spasticity of the upper limb presenting with flexed wrist and clenched fist in adults in various European countries. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 19, 2009 Category: Consumer Health News Tags: Stroke Source Type: news
License extension for Xeomin® (botulinum toxin type A) in EU to include treatment of post-stroke upper limb spasticityEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: PharmaLive
Area: News
The license for Xeomin® (botulinum toxin type A) has been extended in the EU to include the management of post-stroke spasticity of the upper limb presenting with flexed wrist and clenched fist in adults. Xeomin® is already licensed for the symptomatic management of blepharospasm and cervical dystonia of a predominantly rotational form (spasmodic torticollis) in adults. The current license extension is based on the Kanovsky study, the largest randomised, placebo-controlled, double-blind trial with a botulinum toxin in upper limb post-stroke spasticity to date. (Source: NeLM - News)
Source: NeLM - News - November 19, 2009 Category: Drugs & Pharmacology Source Type: organizations
Cosmetic surgery 'needs regulation'Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Several newspapers have reported the dangers associated with cosmetic surgery, including a lack of regulation in some areas of the industry. The reports also feature warnings from Nigel Mercer, the president of the British Association of Aesthetic Plastic Surgeons, who voiced his views as part of a series of medical articles on cosmetic surgery. Mr Mercer called for tighter regulation and testing of drugs, procedures and implants to offer more protection to patients.
The Times reported that the number of cosmetic surgical operations conducted by “audited members of the profession” has more than tripled to 34,000 since ...
Source: NHS News Feed - November 16, 2009 Category: Consumer Health News Tags: Medical practice Source Type: news
Botox Takes A Shot At PainEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
No longer just a wrinkle fighter, Botox may have indications as a pain medication to fight Chronic Regional Pain Syndrome (CRPS), according to a new study. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - November 10, 2009 Category: Science Source Type: news
The Lowe Law Firm Files Suit Over Alleged Botox OverdoseEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
St. Louis-based The Lowe Law Firm has filed a lawsuit on behalf of a man who experienced partial respiratory paralysis and other side effects after receiving an overdose of the Botox being used to treat his muscle spasticity. The suit, Richard A. Hart v. Yi Pan, Tenet HealthSystem SL Inc., d/b/a St. Louis University Hospital and Allergan USA Inc., cause no. 0922-CC09485, was filed in St. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 9, 2009 Category: Consumer Health News Tags: Cosmetic Medicine / Plastic Surgery Source Type: news
The Lowe Law Firm Files Suit Over Alleged Botox OverdoseEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
St. Louis-based The Lowe Law Firm has filed a lawsuit on behalf of a man who experienced partial respiratory paralysis and other side effects after receiving an overdose of the Botox being used to treat his muscle spasticity. The suit, Richard A. Hart v. Yi Pan, Tenet HealthSystem SL Inc., d/b/a St. Louis University Hospital and Allergan USA Inc., cause no. 0922-CC09485, was filed in St. Louis Circuit Court on Oct. 21. (Source: Cosmetic Medicine / Plastic Surgery News From Medical News Today)
Source: Cosmetic Medicine / Plastic Surgery News From Medical News Today - November 9, 2009 Category: Cosmetic Surgery Tags: Cosmetic Medicine / Plastic Surgery Source Type: news
Botox gets a rival - but should you fall for the lure of Azzalure?Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A serious contender to the celebrities' favourite frown-freezer has been launched in the UK. (Source: the Mail online | Health)
Source: the Mail online | Health - November 9, 2009 Category: Consumer Health News Source Type: news
Botox for breasts: New treatment helps women lift sagging cleavageEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
With the treatment taking just half an hour, it is proving popular with busy young mothers who don't have time to go under the knife. (Source: the Mail online | Health)
Source: the Mail online | Health - November 6, 2009 Category: Consumer Health News Source Type: news
Botox May Reduce Frequency of MigrainesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
PHILADELPHIA — OnabotulinumtoxinA appears to be a safe, effective, and well-tolerated headache prophylactic for patients with chronic migraine. Two large randomized controlled trials showed that the toxin significantly reduced migraine frequency and improved headache-related disability over a 24- week period, Dr. David W. Dodick reported at the International Headache Congress. (Source: Skin and Allergy News)
Source: Skin and Allergy News - November 1, 2009 Category: Dermatology Authors: MICHELE G. SULLIVAN Tags: Across Specialties Source Type: journals
Policy & Practice: Can't get enough Policy & Practice? Check out our new podcast each Monday. egmnblog.wordpress.comEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Allergan, the manufacturer of Botox (onabotulinumtoxinA), has sued the Food and Drug Administration, claiming that the agency's restrictions on off-label promotions are inhibiting the company's ability to “proactively share truthful and relevant information with the medical community,” according to a company statement. FDA's constraint that Allergan discuss off-label uses for Botox only in general terms violates the first amendment and hurts patients, Allergan claimed. To fully inform physicians, the company said it needs to describe dosing guidelines, patient selection criteria, and proper injection technique. “We b...
Source: Skin and Allergy News - November 1, 2009 Category: Dermatology Authors: Alicia Ault Tags: Policy & Practice Source Type: journals
Botox May Reduce Frequency of MigrainesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
PHILADELPHIA — OnabotulinumtoxinA appears to be a safe, effective, and well-tolerated headache prophylactic for patients with chronic migraine. Two large randomized, controlled trials showed that the toxin significantly reduced migraine frequency and improved headache-related disability over 24 weeks, Dr. David W. Dodick reported at the International Headache Congress. (Source: Internal Medicine News)
Source: Internal Medicine News - November 1, 2009 Category: Internal Medicine Authors: MICHELE G. SULLIVAN Tags: Neurology Source Type: journals
A double-blind comparison of onabotulinumtoxina (BOTOX) and topiramate (TOPAMAX) for the prophylactic treatment of chronic migraine: a pilot study.Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
CONCLUSIONS: OnabotulinumtoxinA and topiramate demonstrated similar efficacy in the prophylactic treatment of CM. Patients receiving onabotulinumtoxinA had fewer AEs and discontinuations.
PMID: 19912346 [PubMed - in process] (Source: Headache)
Source: Headache - November 1, 2009 Category: Neurology Authors: Mathew NT, Jaffri SF Tags: Headache Source Type: journals
Treatment of congenital esotropia with botulinum toxin type AEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusion: Botulinum toxin type A injections into the medial recti muscles are a valuable alternative to conventional strabismus surgery. (Source: Acta Ophthalmologica)
Source: Acta Ophthalmologica - October 30, 2009 Category: Opthalmology Authors: Kirsten Baggesen, Håvard Magnus Arnljot Source Type: journals
Ipsen Announces the Launch of Dysport(R) (abobotulinumtoxinA) in the United States for the Treatment of Cervical DystoniaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Dysport(R) represents the first new botulinum toxin type A treatment option in eight years to reach the U.S. market place
PARIS--(HSMN NewsFeed)--Ipsen (Paris: IPN ), an innovation-driven global specialty pharmaceutical group, today announced that Dyspo... BiopharmaceuticalsIpsen, Dysport, abobotulinumtoxinA, cervical dystonia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 29, 2009 Category: Pharmaceuticals Source Type: news
Allergan Wants Court To Find Off-Label Promotion Rules Are UnconstitutionalEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
WASHINGTON, D.C. - Already under federal investigation for the off-label marketing of Botox, manufacturer Allergan Inc. on Oct. 1 asked a federal court to declare that federal regulations barring promotion of off-label uses of drugs are an unconstitutional violation of its First Amendment free speech rights (Allergan, Inc. v. United States of America, et al., No. 09-1879, D. D.C.).
Full story on lexis.com (Source: LexisNexis® Mealey's™ Arthritis Drugs Legal News)
Source: LexisNexis® Mealey's™ Arthritis Drugs Legal News - October 29, 2009 Category: Medical Law Source Type: info
Botox as a Breast Lift?Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Title: Botox as a Breast Lift?Category: Health NewsCreated: 10/27/2009 10:02:00 AMLast Editorial Review: 10/27/2009 10:02:27 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - October 27, 2009 Category: Dermatology Source Type: consumer
Botox as a Breast Lift?Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Title: Botox as a Breast Lift?Category: Health NewsCreated: 10/27/2009 10:02:00 AMLast Editorial Review: 10/27/2009 10:02:27 AM (Source: MedicineNet Senior Health General)
Source: MedicineNet Senior Health General - October 27, 2009 Category: Geriatrics Source Type: consumer
Botox as a Breast Lift?Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Title: Botox as a Breast Lift?Category: Health NewsCreated: 10/27/2009 10:02:00 AMLast Editorial Review: 10/27/2009 10:02:27 AM (Source: MedicineNet HIV General)
Source: MedicineNet HIV General - October 27, 2009 Category: Infectious Diseases Source Type: consumer
Botox as a Breast Lift?Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - October 27, 2009 Category: Journals (General) Source Type: info
Botox as a Breast Lift?Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Title: Botox as a Breast Lift?Category: Health NewsCreated: 10/27/2009 10:02:00 AMLast Editorial Review: 10/27/2009 10:02:27 AM (Source: MedicineNet Womens Health General)
Source: MedicineNet Womens Health General - October 27, 2009 Category: OBGYN Source Type: consumer
Botox Fights PainEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Botox may have the power not only to remove wrinkles, but ease pain that's unresponsive to treatments like massage and heat/cold therapy. (Source: Medical Headlines From Ivanhoe.com)
Source: Medical Headlines From Ivanhoe.com - October 27, 2009 Category: Consumer Health News Source Type: news
Botox as a Breast Lift?Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Add breast lifts to the growing list of potential uses for Botox. But not all experts think it's worth the trouble. (Source: WebMD Health)
Source: WebMD Health - October 27, 2009 Category: Consumer Health News Source Type: news
News From Plastic Surgery 2009Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Botox Takes a Shot at Pain No longer just a wrinkle fighter, Botox® may have indications as a pain medication to fight Chronic Regional Pain Syndrome (CRPS), reports a new study presented at the American Society of Plastic Surgeons (ASPS) Plastic Surgery 2009 conference, Oct. 23-27, in Seattle. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 26, 2009 Category: Consumer Health News Tags: Cosmetic Medicine / Plastic Surgery Source Type: news
Supraciliary wrinkles and botulinum toxin AEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusions. Injection of botulinum toxin type A through the temporal hairline to correct supraciliary wrinkles seems to be safe and effective. (Source: Clinical And Experimental Dermatology)
Source: Clinical And Experimental Dermatology - October 22, 2009 Category: Dermatology Authors: F. Ghalamkarpour, R. M. Robati, F. Aryanejad, P. Toossi Source Type: journals
What Is Dystonia?Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Dystonia is a rare neurological movement disorder characterized by involuntary muscle contractions, which force certain parts of the body into abnormal, sometimes painful, movements or postures. It can be inherited due to genetic abnormalities as seen in multiple sclerosis. It can also be caused by brain injuries, toxins and some medications.
Antipsychotic medication, often prescribed in the treatment of bipolar disorder, is one class of drugs that can cause dystonia, which is one of several extrapyramidal side effects. Generally it is the first generation antipsychotics also known as typical antipyschotics that can cause...
Source: About.com Bipolar Disorder - October 19, 2009 Category: Psychiatry Source Type: consumer
Botox sponge may benefit some patients with idiopathic rhinitisEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A nasally-inserted sponge that is soaked with botulinum toxin A provides a minimally invasive, effective alternative to botox injections for patients with treatment-resistant idiopathic rhinitis, research shows. (Source: MedWire News - Respiratory)
Source: MedWire News - Respiratory - October 19, 2009 Category: Respiratory Medicine Source Type: news
Botox sponge treats allergic runny noseEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
GOTTINGEN, Germany, Oct. 16 (UPI) -- Injecting botulinum toxin -- botox -- to treat intrinsic or allergic rhinitis, or runny nose, may be a thing of the past, German researchers said. (Source: Health News - UPI.com)
Source: Health News - UPI.com - October 16, 2009 Category: Consumer Health News Source Type: news
No Need For Needles: Botox Sponge Treats Intrinsic RhinitisEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Injecting botulinum toxin (botox) to treat intrinsic or allergic rhinitis may be a thing of the past as researchers have now shown that sponges soaked in botox are equally effective in treating the condition. The research offers a potential needle-free treatment to the millions of people who suffer from rhinitis. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - October 16, 2009 Category: Science Source Type: news
Botox Sponge Treats Intrinsic Rhinitis Without NeedlesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Injecting botulinum toxin (botox) to treat intrinsic or allergic rhinitis may be a thing of the past as researchers have now shown that sponges soaked in botox are equally effective in treating the condition. The research published in BioMed Central's open access journal Head & Face Medicine offers a potential needle-free treatment to the millions of people who suffer from rhinitis. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 16, 2009 Category: Consumer Health News Tags: Ear, Nose and Throat Source Type: news
Botox Sponge Replaces Needles for Rhinitis PatientsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
German researchers may have found a pain-free treatment for sneezing and sniffling rhinitis patients, replacing needles with soft sponges. (Source: Medical Headlines From Ivanhoe.com)
Source: Medical Headlines From Ivanhoe.com - October 16, 2009 Category: Consumer Health News Source Type: news
Dishler Introduces LatisseEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
We have signed on with Allergan Pharmaceuticals to dispense Latisse for our patients in Denver, Centennial, Aurora and from Colorado Springs and Fort Collins who wish to have longer, thicker, and darker eyelashes. We have received numerous requests from existing patients to offer this product, and although it does not have the "gravity" of LASIK or laser vision correction, it is something that many of our female patients have been requesting. Since Latisse can only be prescribed by medical doctors (MD) and not optometrists (OD) we are also providing this for patients referred by our network of co-mana...
Source: Dishler Laser - October 14, 2009 Category: Laser Surgery Authors: Jon Dishler Source Type: consumer
Smile! It Could Make You HappierEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
We smile because we are happy, and we frown because we are sad. But does the causal arrow point in the other direction, too? A spate of recent studies of botox recipients and others suggests that our emotions are reinforced--perhaps even driven--by their corresponding facial expressions.Charles Darwin first posed the idea that emotional responses influence our feelings in 1872. “The free expression by outward signs of an emotion intensifies it,” he wrote. The esteemed 19th-century psychologist William James went so far as to assert that if a person does not express an emotion, he has not felt it at al...
Source: Scientific American - Official RSS Feed - October 14, 2009 Category: Science Tags: Biology,Health & Medicine,Mind Brain,Everyday Science,Basic Science,Evolution,Neuroscience,Psychology,Thought Cognition Source Type: journals
Oromandibular dystonia and hormonal factors: twelve years follow-up of a case reportEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
We report on a 30-year-old woman affected with OMD with a 12-year follow-up. Focal dystonia involved an involuntary activity of the lateral pterygoid muscles causing forceful jaw displacement in the maximal protrusive position. These episodes initially occurred during jaw function and increased up to an open-lock with bilateral pre-auricular pain. Dystonic spasms were absent during sleep and were reduced temporarily by sensory tricks. Treatment with botulinum toxin type A (BTX) was performed during three different sessions over a 1-year period. Electromyographic-guided BTX injections into the lateral pterygoid muscles were...
Source: Journal of Oral Rehabilitation - October 13, 2009 Category: Dentistry Authors: A. MICHELOTTI, R. SILVA, S. PADUANO, R. CIMINO, M. FARELLA Source Type: journals
Sinitta's frozen shoulder was so painful she couldn't turn her head. Now she's cured - thanks to a Botox injectionEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The former Eighties pop star reveals how she can hardly bear to watch her debut as a presenter last year on TV’s Loose Women. ‘I looked so stiff and wooden,’ she says (Source: the Mail online | Health)
Source: the Mail online | Health - October 13, 2009 Category: Consumer Health News Source Type: news
Merz Pharmaceuticals Announces Phase III Data For NT 201 In Post-stroke Upper Limb SpasticityEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Data results published this month in Clinical Neuropharmacology, revealed that Merz Pharmaceuticals' NT 201 (botulinum toxin type A free from complexing proteins), also known by the brand name Xeomin in Europe and Canada, was statistically significantly more efficacious than placebo for the treatment of patients with post-stroke upper limb spasticity. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 7, 2009 Category: Consumer Health News Tags: Stroke Source Type: news
Effect of Botulinum Toxin Type A on Transforming Growth Factor β1 in Fibroblasts Derived from Hypertrophic Scar: A Preliminary ReportEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Conclusion These results suggest that BTXA effectively inhibited the growth of fibroblasts derived from hypertrophic scar and in turn
caused a decrease in TGF-β1 protein, indicating that BTXA-based therapies for hypertrophic scar are promising and worth investigating
further.
Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s00266-009-9423-zAuthors
Zhibo Xiao, Second Affiliated Hospital of Harbin Medical University Department of Plastic Surgery Harbin City People’s Republic of ChinaFengmin Zhang, College of Basic Medical Science, Harbin Medical University Department of Microbiology ...
Source: Aesthetic Plastic Surgery - October 3, 2009 Category: Cosmetic Surgery Tags: Aesthetic Plastic Surgery Source Type: journals
Botox Maker’s Suit Cites Free SpeechEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Allergan is suing the government, charging that restrictions on telling doctors about unapproved drug uses violates its free-speech rights. (Source: NYT)
Source: NYT - October 3, 2009 Category: American Health Authors: By NATASHA SINGER Tags: Botox (Drug) Advertising and Marketing Drugs (Pharmaceuticals) Freedom of Speech and Expression Source Type: news
Botox Maker’s Suit Cites Free SpeechEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Allergan is suing the government charging that restrictions on telling doctors about unapproved drug uses violates its free-speech rights. (Source: NYT > Health)
Source: NYT > Health - October 3, 2009 Category: Consumer Health News Authors: By NATASHA SINGER Tags: Botox (Drug) Advertising and Marketing Drugs (Pharmaceuticals) Freedom of Speech and Expression Source Type: news
REMS Trigger Suit by Maker of Botulinum ToxinEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The maker of Botox (onabotulinumtoxin A) is asking a federal district court to allow it to share "truthful" information about off-label uses of the drug without risk of penalty from either the FDA or the Department of Justice. (Source: MedPage Today Product Alert)
Source: MedPage Today Product Alert - October 2, 2009 Category: Drugs & Pharmacology Source Type: news
Allergan sues to discuss unapproved uses of drugsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Allergan, the maker of the Botox wrinkle treatment, challenged the government's ban on off-label drug marketing to doctors, saying ... (Source: USATODAY.com Health)
Source: USATODAY.com Health - October 2, 2009 Category: Consumer Health News Source Type: news
Botox Effective in Tough-To-Treat Urinary IncontinenceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
About half of patients with refractory idiopathic detrusor overactivity (IDO) incontinence have complete restoration of continence one month after treatment with botulinum neurotoxin type A (Botox), investigators reported at the 39th Annual Meeting of the International Continence Society (ICS) 2009. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 2, 2009 Category: Consumer Health News Tags: Urology Source Type: news
Allergan Files Federal Lawsuit to Allow It to Share Relevant Information with the Medical Community on the Safe Use of Botox for Common Therapeutic Off-Label TreatmentsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
IRVINE, Calif.--(BUSINESS WIRE)--Oct 2, 2009 - Allergan, Inc.
(NYSE: AGN) today filed a declaratory relief action in the United
States District Court for the District of Columbia seeking a ruling
that would allow Allergan to proactively share... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 2, 2009 Category: Pharmaceuticals Source Type: news
Allergan Suit Seeks to Lift Botox CurbsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Allergan filed a lawsuit against health officials asserting that barring the company from offering information about the unapproved use of Botox violates its free-speech rights. (Source: WSJ.com: Health)
Source: WSJ.com: Health - October 2, 2009 Category: Pharmaceuticals Tags: PAID Source Type: news
Botox Maker Sues to Lift Promotion BanEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Allergan filed a lawsuit against health officials asserting that barring the company from offering information about the unapproved use of Botox violates its free-speech rights. (Source: WSJ.com: Health)
Source: WSJ.com: Health - October 2, 2009 Category: Pharmaceuticals Tags: PAID Source Type: news
